For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.
Scope of the Report:
This report focuses on the Plasma Fractionation in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
North America is the largest supplier of Plasma Fractionation, with production revenue market share about 60%, and the sales market share is 44% in 2015. That is to say, there are a large number of exports in North America, while North America also is the largest consumption region.
Europe, following North America, takes production revenue market share of 20% and the sales market share over 20% in 2015. China is an important market of Plasma Fractionation in Asia, accounting for 11% production revenue market share and 12% sales revenue market share of global market in 2015.
Japan has production revenue market share of 5% and sales revenue market share of 7% nearly in 2015. The local production can meet most local demand, and there is a small amount of imports.
Baxter, CSL, Grifols are the leaders of the industry, with 65% market share in 2015, and hold key technologies and patents. Other manufactures' products are used to meet local demand. With further expanding market, there will be more players in the future.
The worldwide market for Plasma Fractionation is expected to grow at a CAGR of roughly 10.6% over the next five years, will reach 52800 million US$ in 2023, from 28900 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Mitsubishi Tanabe
- Hualan Bio
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Immune Globulin
- Coagulation Factor
Market Segment by Applications, can be divided into
There are 15 Chapters to deeply display the global Plasma Fractionation market.
Chapter 1, to describe Plasma Fractionation Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Plasma Fractionation, with sales, revenue, and price of Plasma Fractionation, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Plasma Fractionation, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Plasma Fractionation market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Plasma Fractionation sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source